02.02.2013 Views

Health Inequities in Manitoba: Is the Socioeconomic Gap

Health Inequities in Manitoba: Is the Socioeconomic Gap

Health Inequities in Manitoba: Is the Socioeconomic Gap

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Appendix 1: Glossary<br />

Adjusted Lorenz Curve for Premature Mortality <strong>in</strong> Urban Areas for 2004–2007<br />

Adjusted by Figure (2004–2007) 3.6: Adjusted age & Lorenz sex, residents Curve for aged Premature 0–74<br />

Mortality <strong>in</strong> Urban Areas for 2004-2007<br />

Adjusted by (2004-2007) age & sex, residents aged 0-74<br />

100%<br />

100.0%<br />

Cumulative Percent of Premature Deaths<br />

80%<br />

60%<br />

40%<br />

20%<br />

0%<br />

202 University of <strong>Manitoba</strong><br />

33.4%<br />

19.5%<br />

U1<br />

54.9%<br />

39.3%<br />

U2<br />

72.8%<br />

59.2%<br />

U3<br />

Cumulative Percent of <strong>the</strong> Population<br />

Lorenz Curve L<strong>in</strong>e of Equality<br />

<strong>Manitoba</strong> <strong>Health</strong><br />

<strong>Manitoba</strong> <strong>Health</strong> is a term describ<strong>in</strong>g <strong>the</strong> prov<strong>in</strong>cial government department <strong>in</strong> <strong>Manitoba</strong> responsible<br />

for healthcare services.<br />

Multiple Sclerosis (MS)<br />

Multiple sclerosis is a degenerative disease of <strong>the</strong> central nervous system (bra<strong>in</strong> and sp<strong>in</strong>al cord).<br />

Its effects are diverse and may <strong>in</strong>clude problems <strong>in</strong> balance, vision, communication, memory, and<br />

movement, as well as more general symptoms such as pa<strong>in</strong> and fatigue. The course of disease varies<br />

between people. Some may have long periods of remission between active episodes, while o<strong>the</strong>rs<br />

may have progression of symptoms from <strong>the</strong> time of onset, and still o<strong>the</strong>rs may have an <strong>in</strong>itial period<br />

of relapses and remissions followed by a progressive course. MS is treatable through a variety of<br />

modalities, with variable impact on <strong>the</strong> progress of <strong>the</strong> disease; however, a cure for MS is not yet<br />

available.<br />

MS prevalence has been calculated as <strong>the</strong> number of cases per 100,000 population aged 16 or older. In<br />

this report, we identified cases of MS meet<strong>in</strong>g <strong>the</strong> follow<strong>in</strong>g criteria: at least three hospital visits, three<br />

physician visits, or a comb<strong>in</strong>ation of <strong>the</strong>se, where each visit <strong>in</strong>cluded a diagnosis code for MS (ICD9 code<br />

340, ICD–10–CA code G35) with<strong>in</strong> a period of six years.<br />

87.8%<br />

GINI = 0.205 (95% CI 0.192, 0.218)<br />

79.6%<br />

U4<br />

100%<br />

U5<br />

Source: <strong>Manitoba</strong> Centre for <strong>Health</strong> Policy, 2010

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!